EFFECT OF A DİETİTİAN-SUPERVİSED LOW-FODMAP DİET VERSUS STANDARD WRİTTEN ADVİCE ON GASTROİNTESTİNAL SYMPTOMS AND INFLAMMATORY BİOMARKERS İN IRRİTABLE BOWEL SYNDROME: A RANDOMİZED CONTROLLED TRİAL
NCT07619573 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2026-06-02
Summary
Background:
Irritable Bowel Syndrome (IBS) is the most prevalent functional gastrointestinal (GI) pathology among GI disorders. Various dietary interventions, particularly the low-FODMAP diet, are employed to alleviate IBS symptoms.
Study Population \& Design:
This study will include 78 adult patients, aged 18-65, diagnosed with IBS according to Rome IV criteria at the Biruni University Faculty of Medicine Hospital Gastroenterology Outpatient Clinic. Participants will be divided into two parallel groups:
Group 1 (n=39): Will receive dietary intervention solely through physician follow-up (provided with a standard hospital brochure listing prohibited foods).
Group 2 (n=39): Will receive structured, personalized dietary intervention through individualized nutritional counseling by a dietitian.
Duration: The low-FODMAP diet intervention for both groups will last for 8 weeks.
Outcome Measures:
At baseline (week 0) and at the conclusion of the study (week 8), the following assessments will be conducted:
Clinical Scores: IBS Symptom Severity Score (IBS-SSS) and the 15-item Gastrointestinal Symptom Rating Scale (GSRS).
Biomarkers: Hs-CRP and fecal calprotectin levels analyzed from blood and stool samples.
Objective:
The primary objective is to determine the impact of individualized nutritional counseling on GI symptoms and inflammatory biomarkers (hs-CRP, fecal calprotectin) during a low-FODMAP diet. Secondary objectives include evaluating the significance of the dietitian's role and observing how lifestyle factors (sleep and physical activity) influence symptom outcomes alongside nutritional therapy.
Conditions
- Irritable Bowel Syndrome (IBS)
Interventions
- BEHAVIORAL
-
Low-FODMAP Diet Intervention
This intervention consists of an 8-week low-FODMAP dietary regimen aimed at restricting the intake of short-chain carbohydrates, including fermentable oligosaccharides, disaccharides, monosaccharides, and polyols. The intervention is administered through two distinct protocols to compare delivery methods: one group receives standard hospital care consisting of a brief physician follow-up accompanied by a standard educational brochure listing prohibited foods, while the other group receives structured, individualized nutritional counseling and personalized meal planning led by a professional dietitian.
Sponsors & Collaborators
-
Biruni University
lead OTHER
Principal Investigators
-
Sevde KAHRAMAN, Asst. Prof. · Biruni University
-
Zeynep Çavdar, Master's student and dietitan · Biruni University
-
Koray Koçhan, Specialist of Gastroenterology · Department of Gastroenterology, Biruni University Faculty of Medicine Hospital
-
Huri Demirci, PhD, Associate Professor · Biruni University
-
Fatma Çelik, PhD, Professor · Biruni University
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2025-04-01
- Primary Completion
- 2025-10-01
- Completion
- 2025-10-30
Countries
- Turkey (Türkiye)
Study Locations
More Related Trials
-
The Effects of FODMAPs in Patients With Irritable Bowel Syndrome
NCT05182593 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Colonic Epithelial Physiology in Diarrhea-predominant Irritable Bowel Syndrome
NCT04542018 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Treatment Effect of Low FODMAP Diet in Treatment of IBS Patients
NCT05144204 ·Status: UNKNOWN ·Phase: NA
-
Effect of FODMAPs on Mucosal Inflammation in IBS Patients
NCT03221790 ·Status: UNKNOWN ·Phase: NA
-
Low FODMAPs Diet vs. Specific Dietary Advice in Patients With IBS Diarrheal Variant
NCT03423069 ·Status: COMPLETED ·Phase: NA
-
Traditional Dietary Advice Versus a Low FODMAP Diet Intake in IBS Patients
NCT02107625 ·Status: COMPLETED ·Phase: NA
-
The Effect of AI-based Microbiome Diet on IBS-M Symptoms
NCT04768387 ·Status: COMPLETED ·Phase: NA
-
Online Low-FODMAP Diet in Irritable Bowel Syndrome
NCT07172581 ·Status: COMPLETED ·Phase: NA
-
Comparison Between Low FODMAP and SSRD in IBS
NCT05192603 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Is Microbiota Community Associated With Clinical Response to a Low FODMAP Diet in Patients With Irritable Bowel Syndrome
NCT02565550 ·Status: UNKNOWN ·Phase: PHASE4
-
Tritordeum-based Foods for IBS Symptoms
NCT05307185 ·Status: COMPLETED ·Phase: NA
-
Efficacy of Low-FODMAPs Dietary Therapy for Irritable Bowel Syndrome in China
NCT03304041 ·Status: COMPLETED ·Phase: NA
-
The Effect of a Low FODMAP Diet in Irritable Bowel Syndrome Patients
NCT04373304 ·Status: UNKNOWN ·Phase: NA
-
(FODMAP) Diet on Improving Symptoms of Patients With Irritable Bowel Syndrome
NCT07299305 ·Status: COMPLETED ·Phase: NA
-
Comparison of Microbiota and Quality of Life for a Low FODMAPs and Standard Dietary in Irritable Bowel Syndrome Patients
NCT02902926 ·Status: UNKNOWN ·Phase: NA
-
Efficacy of a Low FODMAP Diet in IBS Children and Impact on Urinary and Faecal Metabolome
NCT06618677 ·Status: COMPLETED ·Phase: NA
-
Effects of Low FODMAP Diet on Leaky Gut
NCT04526808 ·Status: COMPLETED ·Phase: NA
-
The Impact of Dietary Treatment in Patients With Irritable Bowel Syndrome
NCT04307368 ·Status: COMPLETED ·Phase: NA
-
Diets in Symptom Relief and the Influence of Quality of Life in People With Irritable Bowel Syndrome
NCT02450370 ·Status: COMPLETED ·Phase: NA
-
Identification of Gluten Sensitivity in Irritable Bowel Syndrome
NCT04017585 ·Status: COMPLETED ·Phase: NA
-
Low FODMAPs Diet in Gastrointestinal Disorders
NCT03644602 ·Status: COMPLETED ·Phase: NA
-
Evaluating the Efficacy of the Mediterranean Diet to the Low- Fermentable, Oligosaccharides, Disaccharides, Monosaccharides, and Polyols (FODMAP) Diet in Treating Irritable Bowel Syndrome(IBS)
NCT05807919 ·Status: COMPLETED ·Phase: NA
-
Low FODMAP Diet in Patients With IBS
NCT05618106 ·Status: COMPLETED ·Phase: NA
-
The Stool Microbiome of Treated and Untreated IBS (Irritable Bowel Syndrome) Patients
NCT05972317 ·Status: RECRUITING ·Phase: NA
-
A Mediterranean Approach to Low FODMAP Diet (MED-LFD) for Managing IBS Symptoms
NCT03997708 ·Status: COMPLETED ·Phase: NA